Pfizer Inc.PFENYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+5.2%
5Y CAGR+6.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+5.2%/yr
vs +2.4%/yr prior
5Y CAGR
+6.6%/yr
Consistent
Acceleration
+2.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $28.58B | +12.7% |
| 2024 | $25.36B | +1.3% |
| 2023 | $25.05B | +2.1% |
| 2022 | $24.54B | -5.9% |
| 2021 | $26.08B | +25.4% |
| 2020 | $20.80B | -1.2% |
| 2019 | $21.04B | -5.9% |
| 2018 | $22.35B | -0.1% |
| 2017 | $22.38B | -1.0% |
| 2016 | $22.60B | - |